Single Urine Panel ETG

Product information

Single Panel Drug Urine Rapid Test detects 1 substance with specific result for the substance analyzed.  This urine drug test detects: ETG500.

Advantages of Urine test

• Easy to collect
• No limit to sample volume
• Long detection window

General information

The ETG Rapid Test Panel (Urine) is an immunoassay based on the principle of competitive binding. Drugs which may be present in the urine specimen compete against the drug conjugate for binding sites on the antibody. During testing, a urine specimen migrates upward by capillary action. Ethyl Glucuronide, if present in the urine specimen below 500ng/mL, will not saturate the binding sites of antibody-coated particles in the test device. The antibody-coated particles will then be captured by immobilized Ethyl Glucuronide conjugate and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the Ethyl Glucuronide level exceeds 500ng/mL because it will saturate all the binding sites of anti-Ethyl Glucuronide antibodies.

A drug-positive urine specimen will not generate a colored line in the test line region, while a drug-negative urine specimen or a specimen containing a drug concentration less than the cut-off will generate a line in the test line region. To serve as a procedural control, a colored line will always appear at the control line region indicating that proper volume of specimen has been added and membrane wicking has occurred.

Single Panel Drug Urine Rapid Test screening delivers accurate, quick results for presence of drugs detected in human urine. A rapid test for the simultaneous, qualitative detection of drug and drug metabolites in human urine. This is ideal for healthcare professionals including professionals at point of care sites. Last but not least, the Single Panel Drug Urine Rapid Tests offer economical and reliable, accurate testing for professional use.